newsfilter
← Latest News
Business Wire·

Alnylam to Webcast Conference Call Discussing Third Quarter 2025 Financial Results

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), the leading RNAi therapeutics company, announced today that it will report financial results for the third quarter ending September 30, 2025 on Thursday, October 30, 2025,